Wei L, Li Y, Chen J, Wang Y, Wu J, Yang H
Cell Commun Signal. 2024; 22(1):507.
PMID: 39425166
PMC: 11488268.
DOI: 10.1186/s12964-024-01880-8.
Wang L, Wang X, Zhu X, Zhong L, Jiang Q, Wang Y
Mol Cancer. 2024; 23(1):66.
PMID: 38539161
PMC: 10976737.
DOI: 10.1186/s12943-024-01967-3.
Kim T, Croce C
Exp Mol Med. 2023; 55(7):1314-1321.
PMID: 37430087
PMC: 10394030.
DOI: 10.1038/s12276-023-01050-9.
Wu Y, Huang Y, Wu P, Chang T, Huang S, Chou C
J Ovarian Res. 2023; 16(1):124.
PMID: 37386587
PMC: 10308652.
DOI: 10.1186/s13048-023-01191-5.
Bayraktar E, Bayraktar R, Oztatlici H, Lopez-Berestein G, Amero P, Rodriguez-Aguayo C
Noncoding RNA. 2023; 9(2).
PMID: 37104009
PMC: 10145226.
DOI: 10.3390/ncrna9020027.
The Downregulation of miR-509-3p Expression by Collagen Type XI Alpha 1-Regulated Hypermethylation Facilitates Cancer Progression and Chemoresistance via the DNA Methyltransferase 1/Small Ubiquitin-like Modifier-3 Axis in Ovarian Cancer Cells.
Wu Y, Huang Y, Wu P, Chang T, Huang S, Chou C
Res Sq. 2023; .
PMID: 36865240
PMC: 9980191.
DOI: 10.21203/rs.3.rs-2592453/v1.
FOXD3 confers chemo-sensitivity in ovarian cancer through a miR-335/DAAM1/myosin II axis-dependent mechanism.
Wang S, Ma Y, Hu Y, Zhao X, Li Y, Ouyang S
J Ovarian Res. 2023; 16(1):8.
PMID: 36627652
PMC: 9830800.
DOI: 10.1186/s13048-022-01077-y.
The Profile of MicroRNA Expression and Potential Role in the Regulation of Drug-Resistant Genes in Doxorubicin and Topotecan Resistant Ovarian Cancer Cell Lines.
Stasiak P, Kazmierczak D, Jopek K, Nowicki M, Rucinski M, Januchowski R
Int J Mol Sci. 2022; 23(10).
PMID: 35628654
PMC: 9144982.
DOI: 10.3390/ijms23105846.
Signaling Mediates Chemotherapy-Induced Cancer Cell Stemness in Gastric Cancer.
Xiang X, Ma H, Chen Y, Zhang D, Ma S, Wang H
Front Pharmacol. 2022; 13:855351.
PMID: 35600882
PMC: 9117965.
DOI: 10.3389/fphar.2022.855351.
Cyanidin-3-O-glucoside inhibits the β-catenin/MGMT pathway by upregulating miR-214-5p to reverse chemotherapy resistance in glioma cells.
Zhou Y, Chen L, Ding D, Li Z, Cheng L, You Q
Sci Rep. 2022; 12(1):7773.
PMID: 35545654
PMC: 9095653.
DOI: 10.1038/s41598-022-11757-w.
Tumor-Derived Exosome FGD5-AS1 Promotes Angiogenesis, Vascular Permeability, and Metastasis in Thyroid Cancer by Targeting the miR-6838-5p/VAV2 Axis.
Liu B, Chen J, Shang F, Lian M, Shen X, Fang J
J Oncol. 2022; 2022:4702855.
PMID: 35528244
PMC: 9076303.
DOI: 10.1155/2022/4702855.
Long Noncoding RNA RMRP Contributes to Paclitaxel Sensitivity of Ovarian Cancer by Regulating miR-580-3p/MICU1 Signaling.
Li L, Zeng S, Guo L, Huang P, Xi J, Feng J
J Oncol. 2022; 2022:8301941.
PMID: 35132320
PMC: 8817877.
DOI: 10.1155/2022/8301941.
The Profile of MicroRNA Expression and Potential Role in the Regulation of Drug-Resistant Genes in Cisplatin- and Paclitaxel-Resistant Ovarian Cancer Cell Lines.
Kazmierczak D, Jopek K, Sterzynska K, Nowicki M, Rucinski M, Januchowski R
Int J Mol Sci. 2022; 23(1).
PMID: 35008952
PMC: 8745655.
DOI: 10.3390/ijms23010526.
A novel targeted co-delivery nanosystem for enhanced ovarian cancer treatment via multidrug resistance reversion and mTOR-mediated signaling pathway.
Wang X, Xiong T, Cui M, Li N, Li Q, Zhu L
J Nanobiotechnology. 2021; 19(1):444.
PMID: 34949180
PMC: 8697442.
DOI: 10.1186/s12951-021-01139-1.
MicroRNA and Alternative mRNA Splicing Events in Cancer Drug Response/Resistance: Potent Therapeutic Targets.
Marima R, Francies F, Hull R, Molefi T, Oyomno M, Khanyile R
Biomedicines. 2021; 9(12).
PMID: 34944633
PMC: 8698559.
DOI: 10.3390/biomedicines9121818.
Histone Methyltransferase KMT2D Regulates H3K4 Methylation and is Involved in the Pathogenesis of Ovarian Cancer.
Li M, Shi M, Xu Y, Qiu J, Lv Q
Cell Transplant. 2021; 30:9636897211027521.
PMID: 34705580
PMC: 8554562.
DOI: 10.1177/09636897211027521.
Dacomitinib improves chemosensitivity of cisplatin-resistant human ovarian cancer cells.
Xu L, Xu Y, Zheng J, Zhao Y, Wang H, Qi Y
Oncol Lett. 2021; 22(1):569.
PMID: 34113397
PMC: 8185702.
DOI: 10.3892/ol.2021.12830.
HOXA11-AS induces cisplatin resistance by modulating the microRNA-98/PBX3 axis in nasopharyngeal carcinoma.
Li H, Huang J, Yu S, Li H, Zhou Y, Wu Q
Oncol Lett. 2021; 21(6):493.
PMID: 33968209
PMC: 8100958.
DOI: 10.3892/ol.2021.12754.
lncRNA transcription factor 7 is related to deteriorating clinical features and poor prognosis in multiple myeloma, and its knockdown suppresses disease progression by regulating the miR-203-mediated Jagged1-Notch1 signaling pathway.
Liu H, Shen Y, Xu Y, Wang L, Zhang C, Jiang Y
Oncol Lett. 2021; 21(5):412.
PMID: 33841573
PMC: 8020383.
DOI: 10.3892/ol.2021.12673.
Expression of the chrXq27.3 miRNA cluster in recurrent ovarian clear cell carcinoma and its impact on cisplatin resistance.
Yoshida K, Yokoi A, Sugiyama M, Oda S, Kitami K, Tamauchi S
Oncogene. 2021; 40(7):1255-1268.
PMID: 33420363
PMC: 7892337.
DOI: 10.1038/s41388-020-01595-3.
